J&J single-shot COVID-19 vaccine shows early promiseJ&J has announced early trial results that suggest its single-shot coronavirus vaccine provides a sustained response against the Share XJ&J single-shot COVID-19 vaccine shows early promisehttps://pharmaphorum.com/news/early-data-backs-jjs-single-shot-coronavirus-vaccine-phase-3-results-due-soon/
NICE recommends interim funding for GSK’s Zejula in ovarian cancerWomen with newly-diagnosed advanced ovarian cancer have a new treatment option in England after NICE recommend interim funding Share XNICE recommends interim funding for GSK’s Zejula in ovarian cancerhttps://pharmaphorum.com/news/nice-recommends-interim-funding-for-gsks-zejula-in-ovarian-cancer/
UCB backs epilepsy-focused digital heath startup Nile AIBelgian drugmaker UCB has been steadily building its digital health expertise for several years, and that includes nurturing Share XUCB backs epilepsy-focused digital heath startup Nile AIhttps://pharmaphorum.com/news/ucb-backs-epilepsy-focused-digital-heath-startup-nile-ai/
Celltrion closes in on COVID-19 antibody market after trial successSouth Korea’s Celltrion has announced encouraging top-line results for its potential antibody therapy for COVID-19, with the first Share XCelltrion closes in on COVID-19 antibody market after trial successhttps://pharmaphorum.com/news/celltrion-closes-in-on-covid-19-antibody-market-after-trial-success/
Could Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?When Eli Lilly reported results for donanemab in Alzheimer’s disease earlier this week it was hailed as a Share XCould Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?https://pharmaphorum.com/news/could-lillys-alzheimers-drug-readout-boost-biogens-prospects/
Tivicay approved in Europe in new dispersible tablet for children with HIVViiV’s Tivicay is to become available in Europe in a new dispersible tablet form to treat children living Share XTivicay approved in Europe in new dispersible tablet for children with HIVhttps://pharmaphorum.com/news/tivicay-approved-in-europe-in-new-dispersible-tablet-for-children-with-hiv/
Study says COVID-19 infection provides immunity, but people can transmit virusPrevious COVID-19 infection provides some immunity for at least five months, but people may still carry and transmit Share XStudy says COVID-19 infection provides immunity, but people can transmit virushttps://pharmaphorum.com/news/study-says-covid-19-infection-provides-immunity-but-people-can-transmit-virus/
Synairgen starts dosing inhaled COVID-19 drug in phase 3 trialUK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalised COVID-19 patients, after Share XSynairgen starts dosing inhaled COVID-19 drug in phase 3 trialhttps://pharmaphorum.com/news/synairgen-starts-dosing-inhaled-covid-19-drug-in-phase-3-trial/
Amgen’s Enbrel heads ICER list of unjustified US price risesUS cost effectiveness watchdog ICER found 10 examples of substantial price rises for top-selling medicines in 2019, and Share XAmgen’s Enbrel heads ICER list of unjustified US price riseshttps://pharmaphorum.com/news/icer-lists-top-unjustified-drug-price-rises-headed-by-amgens-enbrel/
